No Data
No Data
Sword of Justice! The US FTC sues three major pharmaceutical "middlemen", vows to correct the distorted profit chain.
The USA's FTC announced on its official website that it has filed a lawsuit against three major "pharmacy benefit managers" and their affiliated organizations, accusing them of engaging in anti-competitive and unfair kickback practices. FTC also "clearly stated" in the declaration its deep concern about the roles played by eli lilly and co, novo-nordisk a/s, sanofi, and other insulin pharmaceutical companies, and the competition bureau may recommend prosecuting these pharmaceutical companies in future enforcement actions.
Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation
Affinia Therapeutics Appoints Rami Daoud as Chief Business and Financial Officer
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Latest Research Highlighting VASCEPA/VAZKEPA (Icosapent Ethyl) REDUCE-IT Subgroup Data and New Mechanistic Insights Into Eicosapentaenoic Acid (EPA) to Be Presented at European Society of Cardiology (ESC) Congress
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading